These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11034635)

  • 1. The role of bisphosphonates in metastatic breast cancer.
    Hillner BE
    Semin Radiat Oncol; 2000 Jul; 10(3):250-3. PubMed ID: 11034635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
    Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
    J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of bisphosphonates in patients with breast cancer.
    Van Poznak CH
    Cancer Control; 2002; 9(6):480-9. PubMed ID: 12514566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience.
    Enright K; Clemons M; Chow E
    Support Care Cancer; 2004 Jan; 12(1):48-52. PubMed ID: 14577020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How are bisphosphonates used today in breast cancer clinical practice?
    Van Poznak C
    Semin Oncol; 2001 Aug; 28(4 Suppl 11):69-74. PubMed ID: 11544580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of bisphosphonate therapy for bone metastasis from breast cancer.
    Oura S; Hirai I; Yoshimasu T; Kokawa Y; Sasaki R
    Breast Cancer; 2003; 10(1):28-32. PubMed ID: 12525760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic bone disease in breast cancer: the patient's perspective.
    Perez EA
    Semin Oncol; 2001 Aug; 28(4 Suppl 11):60-3. PubMed ID: 11544578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bisphosphonates in breast cancer.
    Coleman RE
    Breast; 2004 Dec; 13 Suppl 1():S19-28. PubMed ID: 15585379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials.
    Lipton A; Theriault RL; Hortobagyi GN; Simeone J; Knight RD; Mellars K; Reitsma DJ; Heffernan M; Seaman JJ
    Cancer; 2000 Mar; 88(5):1082-90. PubMed ID: 10699899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of bisphosphonates in skeletal metastasis.
    Elomaa I
    Acta Oncol; 2000; 39(4):445-54. PubMed ID: 11041106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of intravenous bisphosphonates for patients with breast cancer metastatic to bone: a review of randomized, double-blind, phase III trials.
    Gordon DH
    Clin Breast Cancer; 2005 Jun; 6(2):125-31. PubMed ID: 16001990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital setting.
    Barrett-Lee P; Bloomfield D; Dougherty L; Harries M; Laing R; Patel H; Walker M
    Curr Med Res Opin; 2007 Jul; 23(7):1575-82. PubMed ID: 17559749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bisphosphonates and bone metastases].
    Lortholary A; Jadaud E; Berthaud P
    Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.
    Hillner BE; Ingle JN; Chlebowski RT; Gralow J; Yee GC; Janjan NA; Cauley JA; Blumenstein BA; Albain KS; Lipton A; Brown S;
    J Clin Oncol; 2003 Nov; 21(21):4042-57. PubMed ID: 12963702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
    J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pamidronate in the treatment of bone metastases from breast cancer].
    Nagykálnai T; Landherr L; Zatkóné GP; Gyuricska A
    Magy Onkol; 2002; 46(3):225-33. PubMed ID: 12368918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V
    Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.